Skip to main content
Premium Trial:

Request an Annual Quote

Few Tweaks

A group at the University of Texas Southwestern Medical Center has chalked up another retraction — its sixth — and an expression of concern, Retraction Watch reports.

This latest retraction, of a paper in the British Journal of Cancer purporting to show DNA methylation-linked silencing of two genes involved in TGFβ-signaling, is due to "improper manipulation and replication of figures in this paper," according to the retraction notice in the journal.

Retraction Watch notes that other papers from the group, headed by Adi Gazdar, were retracted for similar concerns.

Additionally, the expression of concern, for a paper in Cancer Biology & Therapy that looked at caspase-8 inactivation in lung cancers, also notes image manipulation, but says that there is uncertainty regarding the "impropriety of the manipulation."

A previous Retraction Watch post on the earlier retractions says that a co-author of Gazdar's, Takao Takahashi, had taken responsibility for some of the manipulated images while an unnamed postdoc may have been responsible for others. However, Retraction Watch noted then that "[n]either researcher has acknowledged wrongdoing."

The Scan

Test of the China Initiative

According to Science, the upcoming trial of Harvard University chemist Charles Lieber will test the US China Initiative.

Collaborative Approach

A virologist who spotted the Omicron variant of SARS-CoV-2 tells the Associated Press that its detection was aided by scientific sharing.

Genes of a Guide Dog

Wired reports on a study aimed at uncovering genes involved in being a successful guide dog.

PLOS Papers on RNAs in Metastatic Prostate Cancer, Ebola Field Lab, Embryonic RNA Editing

In PLOS this week: circRNA-mediated ceRNA network points to prostate cancer biomarkers, Ebola testing at frontline field laboratory, and more.